KRAS and lung carcinoma: In addition, the study[73] found that in tumor tissues with metastasis or KRAS mutation, the expression of exosome lncRNA PCAT-1 was significantly up-regulated, which regulated KRAS related chemotherapy tolerance through miR-182/miR217 and closely related to the reduced survival rate and poor prognosis of lung cancer patients.